Items where Author is "Clark, AD"
Up a level |
Jump to: Article
Number of items: 25.
Article
Ahmeti, A;
Preza, I;
Simaku, A;
Nelaj, E;
Clark, AD;
Felix Garcia, AG;
Lara, C;
Hoestlandt, C;
Blau, J;
Bino, S;
(2014)
Cost-effectiveness of rotavirus vaccination in Albania.
Vaccine, 33 Suppl 1.
A201-8.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.075
Full text not available from this repository.
Anwari, P;
Debellut, F;
Pecenka, C;
Parwiz, SM;
Clark, A;
Groman, D;
Safi, N;
(2017)
Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2017.10.058
Blau, J;
Hoestlandt, C;
D Clark, A;
Baxter, L;
Felix Garcia, AG;
Mounaud, B;
Mosina, L;
(2014)
Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Vaccine, 33 Suppl 1.
A34-9.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.073
Full text not available from this repository.
Campos, NG;
Sharma, M;
Clark, A;
Kim, JJ;
Resch, SC;
(2016)
Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
PloS one, 11 (10).
e0164000.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0164000
Campos, NG;
Sharma, M;
Clark, A;
Lee, K;
Geng, F;
Regan, C;
Kim, J;
Resch, S;
(2017)
The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
International journal of gynaecology and obstetrics, 138 Suppl 1.
pp. 47-56.
ISSN 0020-7292
DOI: https://doi.org/10.1002/ijgo.12184
Campos, NG;
Tsu, V;
Jeronimo, J;
Regan, C;
Resch, S;
Clark, A;
Sy, S;
Kim, JJ;
(2018)
Health impact of delayed implementation of cervical cancer screening programs in India: A modelling analysis.
International journal of cancer Journal international du cancer.
ISSN 0020-7136
DOI: https://doi.org/10.1002/ijc.31823
Chang, AY;
Riumallo-Herl, C;
Perales, NA;
Clark, S;
Clark, A;
Constenla, D;
Garske, T;
Jackson, ML;
Jean, K;
Jit, M;
+7 more...
Jones, EO;
LI, X;
Suraratdecha, C;
Bullock, O;
Johnson, H;
Brenzel, L;
Verguet, S;
(2018)
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.
Health affairs (Project Hope), 37 (2).
pp. 316-324.
ISSN 0278-2715
DOI: https://doi.org/10.1377/hlthaff.2017.0861
Clark, A;
Black, R;
Tate, J;
Roose, A;
Kotloff, K;
Lam, D;
Blackwelder, W;
Parashar, U;
Lanata, C;
Kang, G;
+9 more...
Troeger, C;
Platts-Mills, J;
Mokdad, A;
Global Rotavirus Surveillance Network;
Sanderson, C;
Lamberti, L;
Levine, M;
Santosham, M;
Steele, D;
(2017)
Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
PloS one, 12 (9).
e0183392.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0183392
Clark, A;
Jit, M;
Andrews, N;
Atchison, C;
Edmunds, J;
Sanderson, C;
(2014)
Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.04.082
Clark, AD;
Walker, DG;
Mosqueira, NR;
Penny, ME;
Lanata, CF;
Fox-Rushby, J;
Sanderson, CF;
(2009)
Cost-effectiveness of rotavirus vaccination in peru.
The Journal of infectious diseases, 200 Suppl 1.
S114-24.
ISSN 0022-1899
DOI: https://doi.org/10.1086/605043
Full text not available from this repository.
Diop, A;
Atherly, D;
Faye, A;
Lamine Sall, F;
Clark, AD;
Nadiel, L;
Yade, B;
Ndiaye, M;
Fafa Cissé, M;
Ba, M;
(2014)
Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
Vaccine, 33 Suppl 1.
A119-25.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.065
Full text not available from this repository.
Fitzpatrick, MC;
Shah, HA;
Pandey, A;
Bilinski, AM;
Kakkar, M;
Clark, AD;
Townsend, JP;
Abbas, SS;
Galvani, AP;
(2016)
One Health approach to cost-effective rabies control in India.
Proceedings of the National Academy of Sciences of the United States of America, 113 (51).
pp. 14574-14581.
ISSN 0027-8424
DOI: https://doi.org/10.1073/pnas.1604975113
Full text not available from this repository.
Jauregui, B;
Garcia, AG;
Bess Janusz, C;
Blau, J;
Munier, A;
Atherly, D;
Mvundura, M;
Hajjeh, R;
Lopman, B;
Clark, AD;
+4 more...
Baxter, L;
Hutubessy, R;
de Quadros, C;
Andrus, JK;
(2014)
Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
Vaccine, 33 Suppl 1.
A28-33.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.10.090
Full text not available from this repository.
Jauregui, B;
Janusz, CB;
Clark, AD;
Sinha, A;
Garcia, AG;
Resch, S;
Toscano, CM;
Sanderson, C;
Andrus, JK;
(2014)
ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Vaccine, 33 Suppl 1.
A21-7.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.080
Full text not available from this repository.
Jauregui, B;
Sinha, A;
Clark, AD;
Bolanos, BM;
Resch, S;
Toscano, CM;
Matus, CR;
Andrus, JK;
(2011)
Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO's ProVac Initiative.
Vaccine, 29 (5).
pp. 1099-1106.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2010.11.075
Full text not available from this repository.
Kieninger, MP;
Caballero, EG;
Sosa, AA;
Amarilla, CT;
Jáuregui, B;
Janusz, CB;
Clark, AD;
Castellanos, RM;
(2014)
Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay.
Vaccine, 33 Suppl 1.
A143-53.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.078
Full text not available from this repository.
Komakhidze, T;
Hoestlandt, C;
Dolakidze, T;
Shakhnazarova, M;
Chlikadze, R;
Kopaleishvili, N;
Goginashvili, K;
Kherkheulidze, M;
Clark, AD;
Blau, J;
(2014)
Cost-effectiveness of pneumococcal conjugate vaccination in Georgia.
Vaccine, 33 Suppl 1.
A219-26.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.070
Full text not available from this repository.
Mezones-Holguin, E;
Canelo-Aybar, C;
Clark, AD;
Janusz, CB;
Jaúregui, B;
Escobedo-Palza, S;
Hernandez, AV;
Vega-Porras, D;
González, M;
Fiestas, F;
+3 more...
Toledo, W;
Michel, F;
Suárez, VJ;
(2014)
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru.
Vaccine, 33 Suppl 1.
A154-66.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.039
Full text not available from this repository.
Novaes, HM;
de Soárez, PC;
Silva, GA;
Ayres, A;
Itria, A;
Rama, CH;
Sartori, AM;
Clark, AD;
Resch, S;
(2014)
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Vaccine, 33 Suppl 1.
A135-42.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.031
Full text not available from this repository.
Ozawa, S;
Clark, S;
Portnoy, A;
Grewal, S;
Stack, ML;
Sinha, A;
Mirelman, A;
Franklin, H;
Friberg, IK;
Tam, Y;
+11 more...
Walker, N;
Clark, A;
Ferrari, M;
Suraratdecha, C;
Sweet, S;
Goldie, SJ;
Garske, T;
Li, M;
Hansen, PM;
Johnson, HL;
Walker, D;
(2017)
Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
Bulletin of the World Health Organization, 95 (9).
pp. 629-638.
ISSN 0042-9686
DOI: https://doi.org/10.2471/BLT.16.178475
Pecenka, C;
Parashar, U;
Tate, JE;
Khan, JAM;
Groman, D;
Chacko, S;
Shamsuzzaman, M;
Clark, A;
Atherly, D;
(2017)
Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2017.05.087
Riumallo-Herl, C;
Chang, AY;
Clark, S;
Constenla, D;
Clark, A;
Brenzel, L;
Verguet, S;
(2018)
Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study.
BMJ global health, 3 (2).
e000613.
ISSN 2059-7908
DOI: https://doi.org/10.1136/bmjgh-2017-000613
Sigei, C;
Odaga, J;
Mvundura, M;
Madrid, Y;
Clark, AD;
Kenya ProVac Technical Working Group;
Uganda ProVac Technical Working Group;
(2014)
Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Vaccine, 33 Suppl 1.
A109-18.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.079
Full text not available from this repository.
Vučina, VV;
Filipović, SK;
Kožnjak, N;
Stamenić, V;
Clark, AD;
Mounaud, B;
Blau, J;
Hoestlandt, C;
Kaić, B;
(2014)
Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vaccine, 33 Suppl 1.
A209-18.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.043
Full text not available from this repository.
Walwyn, L;
Janusz, CB;
Clark, AD;
Prieto, E;
Waight, E;
Largaespada, N;
(2014)
Cost-effectiveness of HPV vaccination in Belize.
Vaccine, 33 Suppl 1.
A174-81.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.12.042
Full text not available from this repository.